Sinovac Biotech Ltd (NASDAQ:SVA)
| 0.00 Delayed Data As of Dec 30 |  0.00 / 0.00%Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 515.0K | -3.1M | 36.7M | 36.1M | |
| Depreciation | 6.5M | 5.1M | 4.6M | 4.9M | ||
| Total Other Cash Flow | 510.0K | 3.8M | 3.3M | 7.8M | ||
| Funds From Operations | 7.0M | 4.8M | 39.7M | 51.9M | ||
| Funds From/For Other Operating Expenses | 2.7M | 18.7M | -20.0M | 44.0M | ||
| Net Cash Flow - Operating Activities | 4.3M | -13.9M | 59.8M | 7.9M | ||
| Investing | Increase In Investments | 0.00 | 0.00 | 0.00 | -19.7M | |
| Capital Expenditures | -5.3M | -12.7M | -11.9M | -5.6M | ||
| Fixed Asset Disposal | 882.0K | 887.0K | 19.0K | 22.0K | ||
| Other Investing - Uses | -98.0K | -9.0K | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -4.5M | -11.8M | -11.9M | -25.3M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 21.3M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -46.8M | 0.00 | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 750.0K | 315.0K | 1.7M | 85.4M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 544.0K | 6.9M | 2.6M | 3.8M | ||
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -24.2M | 27.8M | -1.3M | 64.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -1.5M | -2.1M | 3.9M | -4.7M | |
| Net Change In Cash | -24.4M | 2.1M | 46.5M | 46.9M | ||
